Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Fiverr International Ltd (FVRR) vs Mesoblast Limited (MESO) Price & Performance

Fiverr International LtdTrade
Mesoblast LimitedTrade

Price performance (Past 24H)

Key statistics

Fiverr International Ltd vs Mesoblast Limited — how do they compare? Fiverr International Ltd trades at $8.63 (market cap $310.61M), while Mesoblast Limited trades at $13.8 (market cap $1.75B). The key difference: Mesoblast Limited is far larger — about 5.6× Fiverr International Ltd's market cap, and Fiverr International Ltd is more actively traded (381,459 versus 239,027). Which is the better fit depends on your goals — on Pluang, investors hold Fiverr International Ltd for 62 Days and Mesoblast Limited for 14 Days on average.

FVRRMESO
Market Cap
$310.61M$1.75B
Volume
381,459239,027
Sector
MediaHealth
52-Week High
$23.60$20.96
52-Week Low
$8.47$13.19
Typical Hold Time
62 Days14 Days
Enterprise Value
$63.00M$1.83B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Fiverr International Ltd

Fiverr International (FVRR) trades at $8.50, up 0.35% on the day, but has faced recent pressure with two consecutive quarterly earnings misses. The stock shows a bearish technical signal, with moving averages indicating a downtrend, while fundamentals reveal modest revenue growth to $430.91M in 2025 and a net income margin of 4.86%. Recent news highlights AI disruption compressing demand for freelance services, contributing to a 15% stock slump post-Q2 results.

The outlook remains cautious; while valuation ratios like P/E of 10.49 and P/S of 0.74 appear attractive, risks from AI competition and lowered 2026 guidance weigh on sentiment. Analyst consensus is a 'Hold' with a $10.50 price target, suggesting limited upside amid operational headwinds. Investors should balance cheap valuations against execution risks in a shifting gig economy.

Mesoblast Limited

MESO trades at $13.94, up 2.42% with bearish technical signals from moving averages. The company reported substantial revenue growth to $120 million in 2026 but remains unprofitable with a -47.82% net margin. Recent FDA approval for Ryoncil potency assay and completion of Phase 3 back pain trial represent significant operational milestones. Cash position remains strong at $161.16 million, though debt levels require monitoring.

While MESO shows promising revenue growth and pipeline progress, persistent losses and negative ROE present fundamental challenges. Analyst consensus leans bullish with 45% buy ratings, but technical indicators suggest near-term caution. The stock offers speculative growth potential contingent on successful commercialization and path to profitability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Fiverr International Ltd

Fiverr International Ltd is involved in buying and selling digital services in the same fashion as physical goods on an e-commerce platform. It is set out to design a digital marketplace that is built with a comprehensive SKU-like services catalog and a search, finds, and order process that mirrors a typical e-commerce transaction. The service offerings of the company include Graphics and Design, Digital Marketing, Writing and Translation, and Video and Animation among others.

Read more on FVRR →

About Mesoblast Limited

Mesoblast Limited is a global leader in allogeneic cellular medicines. The company develops innovative, commercially-ready mesenchymal lineage cell (MLC) technology for the treatment of various inflammatory and cardiovascular conditions. Their pipeline focuses on leveraging the anti-inflammatory, tissue repair, and immune-modulating properties of these cells for diseases with high unmet medical needs, such as acute graft versus host disease (aGVHD) and chronic heart failure.

Read more on MESO →